Closing the Gaps in Cell & Gene Therapy Manufacturing with Bioprocess Modelling

Cell and gene therapy manufacturing is complex and expensive. Viral vector manufacturing is a significant cost driver. Virica™ uses BioSolve, a bioprocess modelling software, to compare the commercial impacts of a robust 2-fold increase in viral vector yield using Viral Sensitizers (VSE™). Learn how Virica leverages bioproces modelling to demonstrate VSE-driven cost savings.